No Data
No Data
The Market Lifts Nanjing Medlander Medical Technology Co.,Ltd. (SHSE:688273) Shares 29% But It Can Do More
Nanjing Medlander Medical Technology Co.,Ltd. (SHSE:688273) shareholders are no doubt pleased to see that the share price has bounced 29% in the last month, although it is still struggling to make up
Mayland (688273.SH): Cumulative repurchases of 999,900 shares
Gelonghui (688273.SH) announced on March 1, 2024, that as of February 29, 2024, the company had repurchased 999,900 shares of the company's shares through centralized bidding transactions, accounting for 0.9937% of the company's total share capital of 100,620,000 shares. The highest price of the repurchase transaction was 34.44 yuan/share, the lowest price was 23.95 yuan/share, and the total amount of capital paid was RMB 30,024,937.38 (excluding transaction fees such as stamp duty and transaction commissions).
Mayland (688273.SH): Net profit in 2023 fell 27.2% year on year
Glonghui, Feb. 23 | Melande (688273.SH) announced the 2023 annual results report. During the reporting period, the company's total revenue was 34,20.23 million yuan, down 9.25% year on year; operating profit was 10,34398 million yuan, down 29.08% year on year; total profit of 10,2.759 million yuan, down 29.57% year on year; net profit attributable to owners of the parent company after deducting non-recurring profit and loss of 65.2965 million yuan , a year-on-year decrease of 26.33
The medical device sector strengthened, and many other stocks such as Melander rose and stopped
Gelonghui, Feb. 8 | Mailand Biotech rose and stopped 20CM, Zhende Medical and Matilda Biotech went up and down, and Yingkang Life, Lanwei Medicine, and Maipu Medical surged more than 10%. According to news, in January 2024, the State Drug Administration approved the registration of a total of 321 medical device products. Among them, there are 247 domestic Class III medical device products, 41 imported Class III medical device products, and 33 Class II medical device products.
Mayland (688273.SH): A total of 999,900 shares have been repurchased as of January 31
Gelonghui, Feb. 1 | Melande (688273.SH) announced that as of January 31, 2024, the company had repurchased 999,900 shares of the company's shares through centralized bidding transactions, accounting for 0.9937% of the company's total share capital of 100,620,000 shares. The highest price of the repurchase transaction was 34.44 yuan/share, the lowest price was 23.95 yuan/share, and the total amount of capital paid was RMB 30,024,937.38 (excluding transaction fees such as stamp duty and transaction commissions).
Are Nanjing Medlander Medical Technology Co.,Ltd.'s (SHSE:688273) Mixed Financials Driving The Negative Sentiment?
Nanjing Medlander Medical TechnologyLtd (SHSE:688273) has had a rough month with its share price down 18%. We, however decided to study the company's financials to determine if they have got anythin
No Data